Jan 22 2019
Many come for the entertainment, others come for innovation. The Monarch™ Platform has been announced as a finalist for SXSW’s Interactive Innovation Award. Auris Health, creators of the first-of-its-kind technology, and Fjord, Accenture Interactive’s global design and innovation consultancy involved in the development of the system, are being honored for their joint innovation and efforts to revolutionize endoscopy.
The 22nd annual SXSW Interactive Innovation Awards bring together the most groundbreaking and forward-thinking advancements from the digital space. The awards will recognize the most impressive projects in the fields of Artificial Intelligence (AI) & Machine Learning, Health, Med, and BioTech, Music and Audio Innovation, Robotics and Hardware, Speculative Design, Virtual Reality (VR), Augmented Reality (AR) and Mixed Reality (MR), and more.
“We are honored to receive recognition from this respected organization highlighting our breakthrough technology and steadfast commitment to transform interventional medicine,” said Frederic Moll, M.D., founder and CEO of Auris Health. “Our momentum continues to grow, with many leading surgeons and centers currently offering the Monarch Platform to diagnose lung conditions.. We expect continued momentum through 2019 with both our commercialization efforts for endobronchial applications, and continued progress toward our mission to pioneer the next era of medical intervention across a broader spectrum of procedures.”
In order to design the Monarch Platform, Auris Health enlisted the Fjord connected products team who work to bring breakthrough connected products and services to life by redesigning people’s relationships with the world around them. The platform’s design centers on a revolutionary, flexible endoscopic technology that promises to fight lung cancer by enabling physicians to diagnose hard-to-reach, small peripheral nodules earlier and with greater precision than ever before. The platform is designed with clinician ease-of-use in mind, with a dedicated camera and instrument channel, allowing continuous vision without removal of the camera to pass instruments. The robotic system is comprised of a Monarch tower, cart, physical controller, and an instictive physical and digital user interface that combines traditional endoscopic views with computer-assisted navigation based on 3D models of the patient’s own lung anatomy.
“We are thrilled to be recognized for our collaborative work with Auris Health,” said Max Burton, global lead of connected products, Fjord. “Fjord, the design and innovation unit of Accenture Interactive, drew on our experience in user experience, industrial design, UI, visual design, high-fidelity prototyping and design for manufacturing to improve the practice of endoscopy. Inspired by gaming, the result was a surgical system unified by a consistent, instictive physical and digital interface that allows for faster, earlier lung cancer detection – significantly improving patient outcomes and enhancing physicians’ capabilities.”
Learn More About SXSW Awards
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.